These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10731039)

  • 1. Effects of peptidase inhibitors on anti-nociceptive action of dynorphin-(1-8) in rats.
    Kitamura K; Akahori K; Yano H; Iwao K; Oka T
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):273-8. PubMed ID: 10731039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat.
    Ajimi J; Yoshikawa M; Takahashi S; Miura M; Tsukamoto H; Kawaguchi M; Kobayashi H; Suzuki T
    J Anesth; 2015 Feb; 29(1):65-77. PubMed ID: 24943455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of peptidase inhibitors on the enkephalin-induced anti-nociception in rats.
    Taniguchi T; Fan XT; Kitamura K; Oka T
    Jpn J Pharmacol; 1998 Dec; 78(4):487-92. PubMed ID: 9920206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enhancing effects of peptidase inhibitors on the antinociceptive action of [Met5]enkephalin-Arg6-Phe7 in rats.
    Takahashi S; Jin XL; Kosaka K; Yoshikawa M; Kobayashi H; Oka T
    J Pharmacol Sci; 2007 Sep; 105(1):117-21. PubMed ID: 17878706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of [Met5]enkephalin-induced antinociception by mixture of three peptidase inhibitors in rat.
    Murata T; Yoshikawa M; Watanabe M; Takahashi S; Kawaguchi M; Kobayashi H; Suzuki T
    J Anesth; 2014 Oct; 28(5):708-15. PubMed ID: 24705939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
    Hiranuma T; Kitamura K; Taniguchi T; Kanai M; Arai Y; Iwao K; Oka T
    J Pharmacol Exp Ther; 1998 Aug; 286(2):863-9. PubMed ID: 9694943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the subcutaneous administration of enkephalins on tail-flick response and righting reflex of developing rats.
    Oka T; Liu XF; Kajita T; Ohgiya N; Ghoda K; Taniguchi T; Arai Y; Matsumiya T
    Brain Res Dev Brain Res; 1992 Oct; 69(2):271-6. PubMed ID: 1424102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Great increase in antinociceptive potency of [Leu5]enkephalin after peptidase inhibition.
    Akahori K; Kosaka K; Jin XL; Arai Y; Yoshikawa M; Kobayashi H; Oka T
    J Pharmacol Sci; 2008 Feb; 106(2):295-300. PubMed ID: 18296865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Met5]enkephalin-Arg-Gly-Leu-induced antinociception is greatly increased by peptidase inhibitors.
    Kanai M; Takahashi S; Kosaka K; Iwao K; Kobayashi H; Oka T
    Eur J Pharmacol; 2002 Oct; 453(1):53-8. PubMed ID: 12393059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in antinociceptive effect of [leu5]enkephalin after intrathecal administration of mixture of three peptidase inhibitors.
    Miura M; Yoshikawa M; Watanabe M; Takahashi S; Ajimi J; Ito K; Ito M; Kawaguchi M; Kobayashi H; Suzuki T
    Tokai J Exp Clin Med; 2013 Jul; 38(2):62-70. PubMed ID: 23868737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides.
    Hiranuma T; Kitamura K; Taniguchi T; Kobayashi T; Tamaki R; Kanai M; Akahori K; Iwao K; Oka T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):276-82. PubMed ID: 9550299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test.
    Tan-No K; Ohshima K; Taira A; Inoue M; Niijima F; Nakagawasai O; Tadano T; Nylander I; Silberring J; Terenius L; Kisara K
    Brain Res; 2001 Feb; 891(1-2):274-80. PubMed ID: 11164832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidon) on Met-enkephalin-, beta-endorphin-, dynorphin-(1-13)- and electroacupuncture-induced antinociception in rats.
    Kishioka S; Miyamoto Y; Fukunaga Y; Nishida S; Yamamoto H
    Jpn J Pharmacol; 1994 Nov; 66(3):337-45. PubMed ID: 7869621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
    Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
    Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
    J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.
    Song B; Marvizón JC
    J Neurosci; 2003 Mar; 23(5):1847-58. PubMed ID: 12629189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats.
    Ballet S; Mauborgne A; Hamon M; Cesselin F; Collin E
    Synapse; 2000 Sep; 37(4):262-72. PubMed ID: 10891863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of dynorphin-(1-8) in isolated preparations by three peptidases.
    Numata H; Hiranuma T; Oka T
    Jpn J Pharmacol; 1988 Aug; 47(4):417-23. PubMed ID: 2903264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin-(1-13): antinociceptive action and its effects on morphine analgesia and acute tolerance.
    Kishioka S; Morita N; Kitabata Y; Yamanishi T; Miyamoto Y; Ozaki M; Yamamoto H
    Jpn J Pharmacol; 1992 Nov; 60(3):197-207. PubMed ID: 1362787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.